Daicel Life Sciences
Daicel Life Sciences provides products and services to a wide array of the pharmaceutical market. In the area of drug delivery, we offer Daicel’s P1 SC jet-injector, approved in Japan for sub-cutaneous delivery in humans (2025). This needle-free device is designed to inject drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, our Actranza jet-injector has been proven to deliver mRNA and DNA into the cell (SC or IM) and achieve production of the desired protein or antibody.